News2026-10-30 10:52 UTC

Neuralink’s Blindsight Implant Ready for Engineering Review

Neuralink announced its Blindsight device, designed to restore vision, has received FDA Breakthrough Device Designation and awaits regulatory approval before commercial release.

More News

10-30 10:52 UTCDoorDash to Acquire Instacart for $17 Billion
10-30 10:52 UTCReddit Tests Logged‑In‑Only Experience in Select Non‑US Markets
10-30 10:52 UTCBinance Suspends Transactions After $6.3 Billion Hack
10-30 10:52 UTCNVIDIA Executive Allegedly Targeted by Chinese Spy Plot
10-30 11:01 UTCSilent Payments Protocol for Multiparty Wallets